{"transactions":[{"id":1087233,"issuer":{"id":8639,"kind":"organization","name":"ZyVersa Therapeutics, Inc."},"owners":[{"id":77498,"kind":"person","name":"Finizio Robert G","position":1,"cik":"0001532235","reported_name":"Finizio Robert G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2025-07-15T16:22:54.000Z","date":"2025-07-11","kind":"grant","planned":false,"acquired":true,"shares":11066,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options were granted on July 11, 2025, and vest and become exercisable in equal annual installments on the first three anniversaries of the grant date, subject to the Reporting Person's continued service on each such vesting date."}],"balance_after":11066,"derivative":{"exercise_price":0.59,"expiration_date":"2035-07-11","underlying":"Common Stock","underlying_shares":11066},"source":{"system":"sec-edgar","filing":"0001641172-25-019723","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1532235/000164117225019723/ownership.xml","form_type":"4"}},{"id":1451684,"issuer":{"id":8639,"kind":"organization","name":"ZyVersa Therapeutics, Inc."},"owners":[{"id":77498,"kind":"person","name":"Finizio Robert G","position":1,"cik":"0001532235","reported_name":"Finizio Robert G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2024-07-18T21:35:05.000Z","date":"2023-05-24","kind":"grant","planned":false,"acquired":true,"shares":132,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"The option disclosed on this Form 4 was not previously reported due to an administrative oversight."},{"field":"shares","element":"transactionShares","label":"F2","text":"Share and dollar amounts give effect to the issuer's 1-for-35 reverse stock split effectuated on December 4, 2023, and 1-for-10 reverse stock split effectuated on April 25, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vests annually in three equal installments commencing on May 24, 2024."}],"balance_after":132,"derivative":{"exercise_price":152.46,"expiration_date":"2033-05-24","underlying":"Common Stock","underlying_shares":132},"source":{"system":"sec-edgar","filing":"0001493152-24-028402","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1532235/000149315224028402/ownership.xml","form_type":"4"}},{"id":2086176,"issuer":{"id":8639,"kind":"organization","name":"ZyVersa Therapeutics, Inc."},"owners":[{"id":77498,"kind":"person","name":"Finizio Robert G","position":1,"cik":"0001532235","reported_name":"Finizio Robert G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (right to buy)","published_at":"2022-12-14T19:40:42.000Z","date":"2022-12-12","kind":"grant","acquired":true,"shares":9927,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vests in 3 equal annual installments commencing on January 28, 2023."}],"balance_after":9927,"derivative":{"exercise_price":16.36,"expiration_date":"2032-01-28","underlying":"Common Stock","underlying_shares":9927},"source":{"system":"sec-edgar","filing":"0001493152-22-035489","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1532235/000149315222035489/ownership.xml","form_type":"4"}},{"id":2086175,"issuer":{"id":8639,"kind":"organization","name":"ZyVersa Therapeutics, Inc."},"owners":[{"id":77498,"kind":"person","name":"Finizio Robert G","position":1,"cik":"0001532235","reported_name":"Finizio Robert G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (right to buy)","published_at":"2022-12-14T19:40:42.000Z","date":"2022-12-12","kind":"grant","acquired":true,"shares":19854,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests in 3 equal annual installments commencing on February 8, 2022."}],"balance_after":19854,"derivative":{"exercise_price":16.36,"expiration_date":"2031-02-08","underlying":"Common Stock","underlying_shares":19854},"source":{"system":"sec-edgar","filing":"0001493152-22-035489","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1532235/000149315222035489/ownership.xml","form_type":"4"}},{"id":2086174,"issuer":{"id":8639,"kind":"organization","name":"ZyVersa Therapeutics, Inc."},"owners":[{"id":77498,"kind":"person","name":"Finizio Robert G","position":1,"cik":"0001532235","reported_name":"Finizio Robert G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (right to buy)","published_at":"2022-12-14T19:40:42.000Z","date":"2022-12-12","kind":"grant","acquired":true,"shares":29781,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the option is immediately exercisable. The option vested in 3 equal annual installments commencing on April 2, 2020."}],"balance_after":29781,"derivative":{"exercise_price":11.58,"expiration_date":"2029-04-02","underlying":"Common Stock","underlying_shares":29781},"source":{"system":"sec-edgar","filing":"0001493152-22-035489","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1532235/000149315222035489/ownership.xml","form_type":"4"}},{"id":2646984,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":77498,"kind":"person","name":"Finizio Robert G","position":1,"cik":"0001532235","reported_name":"Finizio Robert G","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Restricted Stock Units","published_at":"2021-07-02T21:54:22.000Z","date":"2021-07-01","kind":"grant","acquired":true,"shares":746667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each restricted stock unit (RSU) represents a contingent right to receive one share of common stock of the issuer. The RSUs will vest in three equal installments annually beginning July 1, 2022, becoming fully vested on July 1, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each restricted stock unit (RSU) represents a contingent right to receive one share of common stock of the issuer. The RSUs will vest in three equal installments annually beginning July 1, 2022, becoming fully vested on July 1, 2024."}],"balance_after":746667,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":746667},"source":{"system":"sec-edgar","filing":"0001387131-21-007122","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713121007122/ownership.xml","form_type":"4"}},{"id":2646983,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":77498,"kind":"person","name":"Finizio Robert G","position":1,"cik":"0001532235","reported_name":"Finizio Robert G","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Performance Stock Units","published_at":"2021-07-02T21:54:22.000Z","date":"2021-07-01","kind":"grant","acquired":true,"shares":1493333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"One half of the performance stock units (PSUs) vest based on the issuer achieving certain revenue milestones over the period from 2021 through 2023, and one half of the PSUs vest based on the issuer achieving certain earnings before interest, taxes, depreciation and amortization (EBITDA) milestones no later than December 31, 2023. In the event that any of the foregoing are not achieved, the corresponding portion of the PSUs will be forfeited. The number of PSUs listed is the base number of PSUs that may vest. The actual number of PSUs that will vest will be between zero and two times the base number of PSUs depending on the milestones achieved. In accordance with the terms of the issuer's 2019 Stock Incentive Plan, no PSUs will vest prior to the one-year anniversary of the grant date. Each PSU represents a contingent right to receive one share of common stock of the issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One half of the performance stock units (PSUs) vest based on the issuer achieving certain revenue milestones over the period from 2021 through 2023, and one half of the PSUs vest based on the issuer achieving certain earnings before interest, taxes, depreciation and amortization (EBITDA) milestones no later than December 31, 2023. In the event that any of the foregoing are not achieved, the corresponding portion of the PSUs will be forfeited. The number of PSUs listed is the base number of PSUs that may vest. The actual number of PSUs that will vest will be between zero and two times the base number of PSUs depending on the milestones achieved. In accordance with the terms of the issuer's 2019 Stock Incentive Plan, no PSUs will vest prior to the one-year anniversary of the grant date. Each PSU represents a contingent right to receive one share of common stock of the issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"One half of the performance stock units (PSUs) vest based on the issuer achieving certain revenue milestones over the period from 2021 through 2023, and one half of the PSUs vest based on the issuer achieving certain earnings before interest, taxes, depreciation and amortization (EBITDA) milestones no later than December 31, 2023. In the event that any of the foregoing are not achieved, the corresponding portion of the PSUs will be forfeited. The number of PSUs listed is the base number of PSUs that may vest. The actual number of PSUs that will vest will be between zero and two times the base number of PSUs depending on the milestones achieved. In accordance with the terms of the issuer's 2019 Stock Incentive Plan, no PSUs will vest prior to the one-year anniversary of the grant date. Each PSU represents a contingent right to receive one share of common stock of the issuer."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"One half of the performance stock units (PSUs) vest based on the issuer achieving certain revenue milestones over the period from 2021 through 2023, and one half of the PSUs vest based on the issuer achieving certain earnings before interest, taxes, depreciation and amortization (EBITDA) milestones no later than December 31, 2023. In the event that any of the foregoing are not achieved, the corresponding portion of the PSUs will be forfeited. The number of PSUs listed is the base number of PSUs that may vest. The actual number of PSUs that will vest will be between zero and two times the base number of PSUs depending on the milestones achieved. In accordance with the terms of the issuer's 2019 Stock Incentive Plan, no PSUs will vest prior to the one-year anniversary of the grant date. Each PSU represents a contingent right to receive one share of common stock of the issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"One half of the performance stock units (PSUs) vest based on the issuer achieving certain revenue milestones over the period from 2021 through 2023, and one half of the PSUs vest based on the issuer achieving certain earnings before interest, taxes, depreciation and amortization (EBITDA) milestones no later than December 31, 2023. In the event that any of the foregoing are not achieved, the corresponding portion of the PSUs will be forfeited. The number of PSUs listed is the base number of PSUs that may vest. The actual number of PSUs that will vest will be between zero and two times the base number of PSUs depending on the milestones achieved. In accordance with the terms of the issuer's 2019 Stock Incentive Plan, no PSUs will vest prior to the one-year anniversary of the grant date. Each PSU represents a contingent right to receive one share of common stock of the issuer."}],"balance_after":1493333,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":1493333},"source":{"system":"sec-edgar","filing":"0001387131-21-007122","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713121007122/ownership.xml","form_type":"4"}},{"id":2717888,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":77498,"kind":"person","name":"Finizio Robert G","position":1,"cik":"0001532235","reported_name":"Finizio Robert G","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Restricted Stock Units","published_at":"2021-05-13T00:36:15.000Z","date":"2021-05-10","kind":"exercise","acquired":false,"shares":158334,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On May 10, 2021, the reporting person received 158,334 shares of issuer common stock in settlement of restricted stock units (RSUs), which vested on March 30, 2021."},{"field":"shares","element":"transactionShares","label":"F4","text":"Each RSU represents a contingent right to receive one share of issuer common stock upon settlement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The RSUs vest in three equal installments annually beginning March 30, 2021, becoming fully vested on March 30, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The RSUs vest in three equal installments annually beginning March 30, 2021, becoming fully vested on March 30, 2023."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Each RSU represents a contingent right to receive one share of issuer common stock upon settlement."}],"balance_after":316666,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":158334},"source":{"system":"sec-edgar","filing":"0001387131-21-005565","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713121005565/ownership.xml","form_type":"4"}},{"id":2717887,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":77498,"kind":"person","name":"Finizio Robert G","position":1,"cik":"0001532235","reported_name":"Finizio Robert G","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2021-05-13T00:36:15.000Z","date":"2021-05-11","kind":"sale","acquired":false,"shares":67697,"price":1.04,"value":70404.88,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The reported securities represent shares of issuer common stock sold upon settlement to satisfy tax obligations."}],"balance_after":17991637,"source":{"system":"sec-edgar","filing":"0001387131-21-005565","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713121005565/ownership.xml","form_type":"4"}},{"id":2717886,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":77498,"kind":"person","name":"Finizio Robert G","position":1,"cik":"0001532235","reported_name":"Finizio Robert G","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2021-05-13T00:36:15.000Z","date":"2021-05-10","kind":"exercise","acquired":true,"shares":158334,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On May 10, 2021, the reporting person received 158,334 shares of issuer common stock in settlement of restricted stock units (RSUs), which vested on March 30, 2021."}],"balance_after":18059334,"source":{"system":"sec-edgar","filing":"0001387131-21-005565","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713121005565/ownership.xml","form_type":"4"}},{"id":2805067,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":77498,"kind":"person","name":"Finizio Robert G","position":1,"cik":"0001532235","reported_name":"Finizio Robert G","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Warrants (right to buy)","published_at":"2021-03-09T02:07:30.000Z","date":"2021-03-04","kind":"other","acquired":false,"shares":179000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The warrant vested quarterly in eight equal installments commencing June 30, 2011, becoming fully-vested on March 31, 2013."}],"balance_after":0,"derivative":{"exercise_price":0.2444,"expiration_date":"2021-03-06","underlying":"Common Stock","underlying_shares":179000},"source":{"system":"sec-edgar","filing":"0001387131-21-003349","document":"finizio-form4_030421.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713121003349/finizio-form4_030421.xml","form_type":"4"}},{"id":2805066,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":77498,"kind":"person","name":"Finizio Robert G","position":1,"cik":"0001532235","reported_name":"Finizio Robert G","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2021-03-09T02:07:30.000Z","date":"2020-02-28","kind":"gift","acquired":false,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":17901000,"source":{"system":"sec-edgar","filing":"0001387131-21-003349","document":"finizio-form4_030421.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713121003349/finizio-form4_030421.xml","form_type":"4"}},{"id":2805065,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":77498,"kind":"person","name":"Finizio Robert G","position":1,"cik":"0001532235","reported_name":"Finizio Robert G","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2021-03-09T02:07:30.000Z","date":"2021-03-05","kind":"gift","acquired":false,"shares":350000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":18201000,"source":{"system":"sec-edgar","filing":"0001387131-21-003349","document":"finizio-form4_030421.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713121003349/finizio-form4_030421.xml","form_type":"4"}},{"id":2805064,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":77498,"kind":"person","name":"Finizio Robert G","position":1,"cik":"0001532235","reported_name":"Finizio Robert G","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2021-03-09T02:07:30.000Z","date":"2021-03-04","kind":"tax_withholding","acquired":false,"shares":29964,"price":1.46,"value":43747.44,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On March 4, 2021, the reporting person exercised a warrant to purchase 179,000 shares of issuer common stock for $0.2444 per share. The reporting person paid the exercise price on a cashless basis, resulting in the issuer's withholding of 29,964 of the warrant shares to pay the exercise price and issuing to the reporting person the remaining 149,036 shares."}],"balance_after":18551000,"source":{"system":"sec-edgar","filing":"0001387131-21-003349","document":"finizio-form4_030421.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713121003349/finizio-form4_030421.xml","form_type":"4"}},{"id":2805063,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":77498,"kind":"person","name":"Finizio Robert G","position":1,"cik":"0001532235","reported_name":"Finizio Robert G","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2021-03-09T02:07:30.000Z","date":"2021-03-04","kind":"other","acquired":true,"shares":179000,"price":0.2444,"value":43747.6,"ownership":{"direct":true},"balance_after":18580964,"source":{"system":"sec-edgar","filing":"0001387131-21-003349","document":"finizio-form4_030421.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713121003349/finizio-form4_030421.xml","form_type":"4"}},{"id":2965622,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":77498,"kind":"person","name":"Finizio Robert G","position":1,"cik":"0001532235","reported_name":"Finizio Robert G","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Restricted Stock Unit","published_at":"2020-11-27T22:01:27.000Z","date":"2020-11-24","kind":"grant","acquired":true,"shares":1,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The restricted stock unit (RSU) represents a contingent right to receive one share of common stock of the issuer. The RSU will vest on November 24, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The restricted stock unit (RSU) represents a contingent right to receive one share of common stock of the issuer. The RSU will vest on November 24, 2022."}],"balance_after":1,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":1},"source":{"system":"sec-edgar","filing":"0001387131-20-010304","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713120010304/ownership.xml","form_type":"4"}},{"id":3115710,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":77498,"kind":"person","name":"Finizio Robert G","position":1,"cik":"0001532235","reported_name":"Finizio Robert G","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2020-06-10T20:06:02.000Z","date":"2020-06-09","kind":"purchase","acquired":true,"shares":25000,"price":1.47,"value":36750.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.46 to $1.47, inclusive. The reporting person undertakes to provide to TherapeuticsMD, Inc., any security holder of TherapeuticsMD, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in Footnote (1) to this Form 4."}],"balance_after":18401964,"source":{"system":"sec-edgar","filing":"0001387131-20-005580","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713120005580/ownership.xml","form_type":"4"}},{"id":3115709,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":77498,"kind":"person","name":"Finizio Robert G","position":1,"cik":"0001532235","reported_name":"Finizio Robert G","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2020-06-10T20:06:02.000Z","date":"2020-06-09","kind":"purchase","acquired":true,"shares":21000,"price":1.41,"value":29610.0,"ownership":{"direct":true},"balance_after":18376964,"source":{"system":"sec-edgar","filing":"0001387131-20-005580","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713120005580/ownership.xml","form_type":"4"}},{"id":3119719,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":77498,"kind":"person","name":"Finizio Robert G","position":1,"cik":"0001532235","reported_name":"Finizio Robert G","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2020-06-08T20:07:40.000Z","date":"2020-06-05","kind":"purchase","acquired":true,"shares":20000,"price":1.15,"value":23000.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.14 to $1.15, inclusive. The reporting person undertakes to provide to TherapeuticsMD, Inc., any security holder of TherapeuticsMD, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in Footnote (2) to this Form 4."}],"balance_after":18355964,"source":{"system":"sec-edgar","filing":"0001387131-20-005521","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713120005521/ownership.xml","form_type":"4"}},{"id":3119718,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":77498,"kind":"person","name":"Finizio Robert G","position":1,"cik":"0001532235","reported_name":"Finizio Robert G","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2020-06-08T20:07:40.000Z","date":"2020-06-05","kind":"purchase","acquired":true,"shares":10000,"price":1.16,"value":11600.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.16 to $1.17, inclusive. The reporting person undertakes to provide to TherapeuticsMD, Inc., any security holder of TherapeuticsMD, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in Footnote (1) to this Form 4."}],"balance_after":18335964,"source":{"system":"sec-edgar","filing":"0001387131-20-005521","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713120005521/ownership.xml","form_type":"4"}},{"id":3190258,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":77498,"kind":"person","name":"Finizio Robert G","position":1,"cik":"0001532235","reported_name":"Finizio Robert G","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Restricted Stock Units","published_at":"2020-04-02T00:32:56.000Z","date":"2020-03-30","kind":"grant","acquired":true,"shares":475000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each restricted stock unit (RSU) represents a contingent right to receive one share of common stock of the issuer. The RSUs will vest in three equal installments annually beginning March 30, 2021, becoming fully vested on March 30, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each restricted stock unit (RSU) represents a contingent right to receive one share of common stock of the issuer. The RSUs will vest in three equal installments annually beginning March 30, 2021, becoming fully vested on March 30, 2023."}],"balance_after":475000,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":475000},"source":{"system":"sec-edgar","filing":"0001387131-20-003592","document":"finizio-form4_033020.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713120003592/finizio-form4_033020.xml","form_type":"4"}},{"id":3190257,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":77498,"kind":"person","name":"Finizio Robert G","position":1,"cik":"0001532235","reported_name":"Finizio Robert G","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Performance Stock Units","published_at":"2020-04-02T00:32:56.000Z","date":"2020-03-30","kind":"grant","acquired":true,"shares":475000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The performance stock units (PSUs) vest upon the issuer achieving break-even of quarterly earnings before interest, taxes, depreciation and amortization (EBITDA) for a fiscal quarter no later than the quarter ending December 31, 2022, otherwise the PSUs will be forfeited. The number of PSUs listed is the base number of PSUs that may vest. The actual number of PSUs that will vest will be between zero and two times the base number of PSUs depending on when the issuer achieves break-even of quarterly EBITDA. In accordance with the terms of the issuer's 2019 Stock Incentive Plan, no PSUs will vest prior to the one-year anniversary of the grant date. Each PSU represents a contingent right to receive one share of common stock of the issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The performance stock units (PSUs) vest upon the issuer achieving break-even of quarterly earnings before interest, taxes, depreciation and amortization (EBITDA) for a fiscal quarter no later than the quarter ending December 31, 2022, otherwise the PSUs will be forfeited. The number of PSUs listed is the base number of PSUs that may vest. The actual number of PSUs that will vest will be between zero and two times the base number of PSUs depending on when the issuer achieves break-even of quarterly EBITDA. In accordance with the terms of the issuer's 2019 Stock Incentive Plan, no PSUs will vest prior to the one-year anniversary of the grant date. Each PSU represents a contingent right to receive one share of common stock of the issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The performance stock units (PSUs) vest upon the issuer achieving break-even of quarterly earnings before interest, taxes, depreciation and amortization (EBITDA) for a fiscal quarter no later than the quarter ending December 31, 2022, otherwise the PSUs will be forfeited. The number of PSUs listed is the base number of PSUs that may vest. The actual number of PSUs that will vest will be between zero and two times the base number of PSUs depending on when the issuer achieves break-even of quarterly EBITDA. In accordance with the terms of the issuer's 2019 Stock Incentive Plan, no PSUs will vest prior to the one-year anniversary of the grant date. Each PSU represents a contingent right to receive one share of common stock of the issuer."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"The performance stock units (PSUs) vest upon the issuer achieving break-even of quarterly earnings before interest, taxes, depreciation and amortization (EBITDA) for a fiscal quarter no later than the quarter ending December 31, 2022, otherwise the PSUs will be forfeited. The number of PSUs listed is the base number of PSUs that may vest. The actual number of PSUs that will vest will be between zero and two times the base number of PSUs depending on when the issuer achieves break-even of quarterly EBITDA. In accordance with the terms of the issuer's 2019 Stock Incentive Plan, no PSUs will vest prior to the one-year anniversary of the grant date. Each PSU represents a contingent right to receive one share of common stock of the issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The performance stock units (PSUs) vest upon the issuer achieving break-even of quarterly earnings before interest, taxes, depreciation and amortization (EBITDA) for a fiscal quarter no later than the quarter ending December 31, 2022, otherwise the PSUs will be forfeited. The number of PSUs listed is the base number of PSUs that may vest. The actual number of PSUs that will vest will be between zero and two times the base number of PSUs depending on when the issuer achieves break-even of quarterly EBITDA. In accordance with the terms of the issuer's 2019 Stock Incentive Plan, no PSUs will vest prior to the one-year anniversary of the grant date. Each PSU represents a contingent right to receive one share of common stock of the issuer."}],"balance_after":475000,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":475000},"source":{"system":"sec-edgar","filing":"0001387131-20-003592","document":"finizio-form4_033020.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713120003592/finizio-form4_033020.xml","form_type":"4"}},{"id":3386930,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":77498,"kind":"person","name":"Finizio Robert G","position":1,"cik":"0001532235","reported_name":"Finizio Robert G","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2019-10-29T20:55:43.000Z","date":"2019-10-25","kind":"purchase","acquired":true,"shares":72000,"price":2.75,"value":198000.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a purchase from the underwriters in the issuer's public offering."}],"balance_after":18325964,"source":{"system":"sec-edgar","filing":"0001387131-19-007988","document":"finizio-form4_102519.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713119007988/finizio-form4_102519.xml","form_type":"4"}},{"id":3426476,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":77498,"kind":"person","name":"Finizio Robert G","position":1,"cik":"0001532235","reported_name":"Finizio Robert G","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2019-08-31T01:48:31.000Z","date":"2019-08-28","kind":"grant","acquired":true,"shares":1,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":1,"derivative":{"exercise_price":2.73,"exercise_date":"2022-08-28","expiration_date":"2029-08-28","underlying":"Common Stock","underlying_shares":1},"source":{"system":"sec-edgar","filing":"0001387131-19-006603","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713119006603/ownership.xml","form_type":"4"}},{"id":3433868,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":77498,"kind":"person","name":"Finizio Robert G","position":1,"cik":"0001532235","reported_name":"Finizio Robert G","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2019-08-20T21:12:29.000Z","date":"2019-08-20","kind":"purchase","acquired":true,"shares":35000,"price":2.74,"value":95900.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.70 to $2.79 inclusive. The reporting person undertakes to provide to TherapeuticsMD, Inc., any security holder of TherapeuticsMD, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in Footnote (1) to this Form 4."}],"balance_after":18253964,"source":{"system":"sec-edgar","filing":"0001387131-19-006289","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713119006289/ownership.xml","form_type":"4"}},{"id":3441977,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":77498,"kind":"person","name":"Finizio Robert G","position":1,"cik":"0001532235","reported_name":"Finizio Robert G","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2019-08-12T21:32:56.000Z","date":"2019-08-09","kind":"purchase","acquired":true,"shares":52405,"price":2.96,"value":155118.8,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.85 to $3.00, inclusive. The reporting person undertakes to provide to TherapeuticsMD, Inc., any security holder of TherapeuticsMD, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in Footnote (1) to this Form 4."}],"balance_after":18218964,"source":{"system":"sec-edgar","filing":"0001387131-19-006018","document":"finizio-form4_022819.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713119006018/finizio-form4_022819.xml","form_type":"4"}},{"id":3441976,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":77498,"kind":"person","name":"Finizio Robert G","position":1,"cik":"0001532235","reported_name":"Finizio Robert G","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2019-08-12T21:32:56.000Z","date":"2019-02-28","kind":"gift","acquired":false,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":18166559,"source":{"system":"sec-edgar","filing":"0001387131-19-006018","document":"finizio-form4_022819.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713119006018/finizio-form4_022819.xml","form_type":"4"}},{"id":3723073,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":77498,"kind":"person","name":"Finizio Robert G","position":1,"cik":"0001532235","reported_name":"Finizio Robert G","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2018-12-22T01:02:26.000Z","date":"2018-12-20","kind":"exercise","acquired":false,"shares":92910,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":0.1018,"exercise_date":"2012-01-01","expiration_date":"2019-01-01","underlying":"Common Stock","underlying_shares":92910},"source":{"system":"sec-edgar","filing":"0001387131-18-006984","document":"finizio-form4_121918.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713118006984/finizio-form4_121918.xml","form_type":"4"}},{"id":3723072,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":77498,"kind":"person","name":"Finizio Robert G","position":1,"cik":"0001532235","reported_name":"Finizio Robert G","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2018-12-22T01:02:26.000Z","date":"2018-12-19","kind":"exercise","acquired":false,"shares":92000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":92910,"derivative":{"exercise_price":0.1018,"exercise_date":"2012-01-01","expiration_date":"2019-01-01","underlying":"Common Stock","underlying_shares":92000},"source":{"system":"sec-edgar","filing":"0001387131-18-006984","document":"finizio-form4_121918.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713118006984/finizio-form4_121918.xml","form_type":"4"}},{"id":3723071,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":77498,"kind":"person","name":"Finizio Robert G","position":1,"cik":"0001532235","reported_name":"Finizio Robert G","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2018-12-22T01:02:26.000Z","date":"2018-12-20","kind":"sale","acquired":false,"shares":92910,"price":3.626,"value":336891.66,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales were made pursuant to the Reporting Person's 10b5-1 trading plan with respect to shares of Common Stock underlying options to purchase Common Stock that expire on or before January 1, 2019"},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.51 to $3.845, inclusive. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":18366559,"source":{"system":"sec-edgar","filing":"0001387131-18-006984","document":"finizio-form4_121918.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713118006984/finizio-form4_121918.xml","form_type":"4"}},{"id":3723070,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":77498,"kind":"person","name":"Finizio Robert G","position":1,"cik":"0001532235","reported_name":"Finizio Robert G","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2018-12-22T01:02:26.000Z","date":"2018-12-20","kind":"exercise","acquired":true,"shares":92910,"price":0.1018,"value":9458.238,"ownership":{"direct":true},"balance_after":18459469,"source":{"system":"sec-edgar","filing":"0001387131-18-006984","document":"finizio-form4_121918.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713118006984/finizio-form4_121918.xml","form_type":"4"}},{"id":3723069,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":77498,"kind":"person","name":"Finizio Robert G","position":1,"cik":"0001532235","reported_name":"Finizio Robert G","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2018-12-22T01:02:26.000Z","date":"2018-12-19","kind":"sale","acquired":false,"shares":92000,"price":3.698,"value":340216.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales were made pursuant to the Reporting Person's 10b5-1 trading plan with respect to shares of Common Stock underlying options to purchase Common Stock that expire on or before January 1, 2019"},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.59 to $3.875, inclusive. The reporting person undertakes to provide TherapeuticsMD, Inc. (the \"Company\"), any security holder of the Company, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":18366559,"source":{"system":"sec-edgar","filing":"0001387131-18-006984","document":"finizio-form4_121918.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713118006984/finizio-form4_121918.xml","form_type":"4"}},{"id":3723068,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":77498,"kind":"person","name":"Finizio Robert G","position":1,"cik":"0001532235","reported_name":"Finizio Robert G","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2018-12-22T01:02:26.000Z","date":"2018-12-19","kind":"exercise","acquired":true,"shares":92000,"price":0.1018,"value":9365.6,"ownership":{"direct":true},"balance_after":18458559,"source":{"system":"sec-edgar","filing":"0001387131-18-006984","document":"finizio-form4_121918.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713118006984/finizio-form4_121918.xml","form_type":"4"}},{"id":3738951,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":77498,"kind":"person","name":"Finizio Robert G","position":1,"cik":"0001532235","reported_name":"Finizio Robert G","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2018-12-11T01:03:40.000Z","date":"2018-12-07","kind":"exercise","acquired":false,"shares":92000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":184910,"derivative":{"exercise_price":0.1018,"exercise_date":"2012-01-01","expiration_date":"2019-01-01","underlying":"Common Stock","underlying_shares":92000},"source":{"system":"sec-edgar","filing":"0001387131-18-006727","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713118006727/ownership.xml","form_type":"4"}},{"id":3738950,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":77498,"kind":"person","name":"Finizio Robert G","position":1,"cik":"0001532235","reported_name":"Finizio Robert G","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2018-12-11T01:03:40.000Z","date":"2018-12-06","kind":"exercise","acquired":false,"shares":92000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":276910,"derivative":{"exercise_price":0.1018,"exercise_date":"2012-01-01","expiration_date":"2019-01-01","underlying":"Common Stock","underlying_shares":92000},"source":{"system":"sec-edgar","filing":"0001387131-18-006727","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713118006727/ownership.xml","form_type":"4"}},{"id":3738949,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":77498,"kind":"person","name":"Finizio Robert G","position":1,"cik":"0001532235","reported_name":"Finizio Robert G","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2018-12-11T01:03:40.000Z","date":"2018-12-07","kind":"sale","acquired":false,"shares":92000,"price":4.604,"value":423568.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales were made pursuant to the Reporting Person's 10b5-1 trading plan with respect to shares of Common Stock underlying options to purchase Common Stock that expire on or before January 1, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.505 to $4.725, inclusive. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":18366559,"source":{"system":"sec-edgar","filing":"0001387131-18-006727","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713118006727/ownership.xml","form_type":"4"}},{"id":3738948,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":77498,"kind":"person","name":"Finizio Robert G","position":1,"cik":"0001532235","reported_name":"Finizio Robert G","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2018-12-11T01:03:40.000Z","date":"2018-12-07","kind":"exercise","acquired":true,"shares":92000,"price":0.1018,"value":9365.6,"ownership":{"direct":true},"balance_after":18458559,"source":{"system":"sec-edgar","filing":"0001387131-18-006727","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713118006727/ownership.xml","form_type":"4"}},{"id":3738947,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":77498,"kind":"person","name":"Finizio Robert G","position":1,"cik":"0001532235","reported_name":"Finizio Robert G","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2018-12-11T01:03:40.000Z","date":"2018-12-06","kind":"sale","acquired":false,"shares":92000,"price":4.572,"value":420624.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales were made pursuant to the Reporting Person's 10b5-1 trading plan with respect to shares of Common Stock underlying options to purchase Common Stock that expire on or before January 1, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.44 to $4.7, inclusive. The reporting person undertakes to provide TherapeuticsMD, Inc. (the \"Company\"), any security holder of the Company, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":18366559,"source":{"system":"sec-edgar","filing":"0001387131-18-006727","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713118006727/ownership.xml","form_type":"4"}},{"id":3738946,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":77498,"kind":"person","name":"Finizio Robert G","position":1,"cik":"0001532235","reported_name":"Finizio Robert G","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2018-12-11T01:03:40.000Z","date":"2018-12-06","kind":"exercise","acquired":true,"shares":92000,"price":0.1018,"value":9365.6,"ownership":{"direct":true},"balance_after":18458559,"source":{"system":"sec-edgar","filing":"0001387131-18-006727","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713118006727/ownership.xml","form_type":"4"}},{"id":3738945,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":77498,"kind":"person","name":"Finizio Robert G","position":1,"cik":"0001532235","reported_name":"Finizio Robert G","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2018-12-11T01:03:40.000Z","date":"2018-12-06","kind":"gift","acquired":false,"shares":27000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":18366559,"source":{"system":"sec-edgar","filing":"0001387131-18-006727","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713118006727/ownership.xml","form_type":"4"}},{"id":3751412,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":77498,"kind":"person","name":"Finizio Robert G","position":1,"cik":"0001532235","reported_name":"Finizio Robert G","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2018-11-29T01:01:23.000Z","date":"2018-11-27","kind":"exercise","acquired":false,"shares":92000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":368910,"derivative":{"exercise_price":0.1018,"exercise_date":"2012-01-01","expiration_date":"2019-01-01","underlying":"Common Stock","underlying_shares":92000},"source":{"system":"sec-edgar","filing":"0001387131-18-006419","document":"finizio-form4_112618.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713118006419/finizio-form4_112618.xml","form_type":"4"}},{"id":3751411,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":77498,"kind":"person","name":"Finizio Robert G","position":1,"cik":"0001532235","reported_name":"Finizio Robert G","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2018-11-29T01:01:23.000Z","date":"2018-11-26","kind":"exercise","acquired":false,"shares":92000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":460910,"derivative":{"exercise_price":0.1018,"exercise_date":"2012-01-01","expiration_date":"2019-01-01","underlying":"Common Stock","underlying_shares":92000},"source":{"system":"sec-edgar","filing":"0001387131-18-006419","document":"finizio-form4_112618.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713118006419/finizio-form4_112618.xml","form_type":"4"}},{"id":3751410,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":77498,"kind":"person","name":"Finizio Robert G","position":1,"cik":"0001532235","reported_name":"Finizio Robert G","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2018-11-29T01:01:23.000Z","date":"2018-11-27","kind":"sale","acquired":false,"shares":92000,"price":4.805,"value":442060.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales were made pursuant to the Reporting Person's 10b5-1 trading plan with respect to shares of Common Stock underlying options to purchase Common Stock that expire on or before January 1, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.685 to $4.875, inclusive. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":18393559,"source":{"system":"sec-edgar","filing":"0001387131-18-006419","document":"finizio-form4_112618.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713118006419/finizio-form4_112618.xml","form_type":"4"}},{"id":3751409,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":77498,"kind":"person","name":"Finizio Robert G","position":1,"cik":"0001532235","reported_name":"Finizio Robert G","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2018-11-29T01:01:23.000Z","date":"2018-11-27","kind":"exercise","acquired":true,"shares":92000,"price":0.1018,"value":9365.6,"ownership":{"direct":true},"balance_after":18485559,"source":{"system":"sec-edgar","filing":"0001387131-18-006419","document":"finizio-form4_112618.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713118006419/finizio-form4_112618.xml","form_type":"4"}},{"id":3751408,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":77498,"kind":"person","name":"Finizio Robert G","position":1,"cik":"0001532235","reported_name":"Finizio Robert G","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2018-11-29T01:01:23.000Z","date":"2018-11-26","kind":"sale","acquired":false,"shares":92000,"price":4.859,"value":447028.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales were made pursuant to the Reporting Person's 10b5-1 trading plan with respect to shares of Common Stock underlying options to purchase Common Stock that expire on or before January 1, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.785 to $4.97, inclusive. The reporting person undertakes to provide TherapeuticsMD, Inc. (the \"Company\"), any security holder of the Company, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":18393559,"source":{"system":"sec-edgar","filing":"0001387131-18-006419","document":"finizio-form4_112618.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713118006419/finizio-form4_112618.xml","form_type":"4"}},{"id":3751407,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":77498,"kind":"person","name":"Finizio Robert G","position":1,"cik":"0001532235","reported_name":"Finizio Robert G","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2018-11-29T01:01:23.000Z","date":"2018-11-26","kind":"exercise","acquired":true,"shares":92000,"price":0.1018,"value":9365.6,"ownership":{"direct":true},"balance_after":18485559,"source":{"system":"sec-edgar","filing":"0001387131-18-006419","document":"finizio-form4_112618.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713118006419/finizio-form4_112618.xml","form_type":"4"}},{"id":3766092,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":77498,"kind":"person","name":"Finizio Robert G","position":1,"cik":"0001532235","reported_name":"Finizio Robert G","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2018-11-15T01:02:06.000Z","date":"2018-11-13","kind":"exercise","acquired":false,"shares":92000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":552910,"derivative":{"exercise_price":0.1018,"exercise_date":"2012-01-01","expiration_date":"2019-01-01","underlying":"Common Stock","underlying_shares":92000},"source":{"system":"sec-edgar","filing":"0001387131-18-006220","document":"finizio-form4_111218.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713118006220/finizio-form4_111218.xml","form_type":"4"}},{"id":3766091,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":77498,"kind":"person","name":"Finizio Robert G","position":1,"cik":"0001532235","reported_name":"Finizio Robert G","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2018-11-15T01:02:06.000Z","date":"2018-11-12","kind":"exercise","acquired":false,"shares":92000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":644910,"derivative":{"exercise_price":0.1018,"exercise_date":"2012-01-01","expiration_date":"2019-01-01","underlying":"Common Stock","underlying_shares":92000},"source":{"system":"sec-edgar","filing":"0001387131-18-006220","document":"finizio-form4_111218.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713118006220/finizio-form4_111218.xml","form_type":"4"}},{"id":3766090,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":77498,"kind":"person","name":"Finizio Robert G","position":1,"cik":"0001532235","reported_name":"Finizio Robert G","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2018-11-15T01:02:06.000Z","date":"2018-11-13","kind":"sale","acquired":false,"shares":92000,"price":4.809,"value":442428.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales were made pursuant to the Reporting Person's 10b5-1 trading plan with respect to shares of Common Stock underlying options to purchase Common Stock that expire on or before January 1, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.73 to $4.935, inclusive. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":18393559,"source":{"system":"sec-edgar","filing":"0001387131-18-006220","document":"finizio-form4_111218.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713118006220/finizio-form4_111218.xml","form_type":"4"}},{"id":3766089,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":77498,"kind":"person","name":"Finizio Robert G","position":1,"cik":"0001532235","reported_name":"Finizio Robert G","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2018-11-15T01:02:06.000Z","date":"2018-11-13","kind":"exercise","acquired":true,"shares":92000,"price":0.1018,"value":9365.6,"ownership":{"direct":true},"balance_after":18485559,"source":{"system":"sec-edgar","filing":"0001387131-18-006220","document":"finizio-form4_111218.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713118006220/finizio-form4_111218.xml","form_type":"4"}},{"id":3766088,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":77498,"kind":"person","name":"Finizio Robert G","position":1,"cik":"0001532235","reported_name":"Finizio Robert G","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2018-11-15T01:02:06.000Z","date":"2018-11-12","kind":"sale","acquired":false,"shares":92000,"price":4.73,"value":435160.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales were made pursuant to the Reporting Person's 10b5-1 trading plan with respect to shares of Common Stock underlying options to purchase Common Stock that expire on or before January 1, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.63 to $4.87, inclusive. The reporting person undertakes to provide TherapeuticsMD, Inc. (the \"Company\"), any security holder of the Company, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":18393559,"source":{"system":"sec-edgar","filing":"0001387131-18-006220","document":"finizio-form4_111218.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713118006220/finizio-form4_111218.xml","form_type":"4"}},{"id":3766087,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":77498,"kind":"person","name":"Finizio Robert G","position":1,"cik":"0001532235","reported_name":"Finizio Robert G","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2018-11-15T01:02:06.000Z","date":"2018-11-12","kind":"exercise","acquired":true,"shares":92000,"price":0.1018,"value":9365.6,"ownership":{"direct":true},"balance_after":18485559,"source":{"system":"sec-edgar","filing":"0001387131-18-006220","document":"finizio-form4_111218.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713118006220/finizio-form4_111218.xml","form_type":"4"}},{"id":3782090,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":77498,"kind":"person","name":"Finizio Robert G","position":1,"cik":"0001532235","reported_name":"Finizio Robert G","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2018-10-30T01:00:28.000Z","date":"2018-10-26","kind":"exercise","acquired":false,"shares":92000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":736910,"derivative":{"exercise_price":0.1018,"exercise_date":"2012-01-01","expiration_date":"2019-01-01","underlying":"Common Stock","underlying_shares":92000},"source":{"system":"sec-edgar","filing":"0001387131-18-005729","document":"finizio-form4_102518.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713118005729/finizio-form4_102518.xml","form_type":"4"}},{"id":3782089,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":77498,"kind":"person","name":"Finizio Robert G","position":1,"cik":"0001532235","reported_name":"Finizio Robert G","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2018-10-30T01:00:28.000Z","date":"2018-10-25","kind":"exercise","acquired":false,"shares":92000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":828910,"derivative":{"exercise_price":0.1018,"exercise_date":"2012-01-01","expiration_date":"2019-01-01","underlying":"Common Stock","underlying_shares":92000},"source":{"system":"sec-edgar","filing":"0001387131-18-005729","document":"finizio-form4_102518.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713118005729/finizio-form4_102518.xml","form_type":"4"}},{"id":3782088,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":77498,"kind":"person","name":"Finizio Robert G","position":1,"cik":"0001532235","reported_name":"Finizio Robert G","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2018-10-30T01:00:28.000Z","date":"2018-10-26","kind":"sale","acquired":false,"shares":92000,"price":5.117,"value":470764.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales were made pursuant to the Reporting Person's 10b5-1 trading plan with respect to shares of Common Stock underlying options to purchase Common Stock that expire on or before January 1, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.0 to $5.42, inclusive. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":18393559,"source":{"system":"sec-edgar","filing":"0001387131-18-005729","document":"finizio-form4_102518.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713118005729/finizio-form4_102518.xml","form_type":"4"}},{"id":3782087,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":77498,"kind":"person","name":"Finizio Robert G","position":1,"cik":"0001532235","reported_name":"Finizio Robert G","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2018-10-30T01:00:28.000Z","date":"2018-10-26","kind":"exercise","acquired":true,"shares":92000,"price":0.1018,"value":9365.6,"ownership":{"direct":true},"balance_after":18485559,"source":{"system":"sec-edgar","filing":"0001387131-18-005729","document":"finizio-form4_102518.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713118005729/finizio-form4_102518.xml","form_type":"4"}},{"id":3782086,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":77498,"kind":"person","name":"Finizio Robert G","position":1,"cik":"0001532235","reported_name":"Finizio Robert G","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2018-10-30T01:00:28.000Z","date":"2018-10-25","kind":"sale","acquired":false,"shares":92000,"price":5.449,"value":501308.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales were made pursuant to the Reporting Person's 10b5-1 trading plan with respect to shares of Common Stock underlying options to purchase Common Stock that expire on or before January 1, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.24 to $5.55, inclusive. The reporting person undertakes to provide TherapeuticsMD, Inc. (the \"Company\"), any security holder of the Company, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":18393559,"source":{"system":"sec-edgar","filing":"0001387131-18-005729","document":"finizio-form4_102518.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713118005729/finizio-form4_102518.xml","form_type":"4"}},{"id":3782085,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":77498,"kind":"person","name":"Finizio Robert G","position":1,"cik":"0001532235","reported_name":"Finizio Robert G","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2018-10-30T01:00:28.000Z","date":"2018-10-25","kind":"exercise","acquired":true,"shares":92000,"price":0.1018,"value":9365.6,"ownership":{"direct":true},"balance_after":18485559,"source":{"system":"sec-edgar","filing":"0001387131-18-005729","document":"finizio-form4_102518.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713118005729/finizio-form4_102518.xml","form_type":"4"}},{"id":3791707,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":77498,"kind":"person","name":"Finizio Robert G","position":1,"cik":"0001532235","reported_name":"Finizio Robert G","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2018-10-15T23:01:46.000Z","date":"2018-10-12","kind":"exercise","acquired":false,"shares":92000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":920910,"derivative":{"exercise_price":0.1018,"exercise_date":"2012-01-01","expiration_date":"2019-01-01","underlying":"Common Stock","underlying_shares":92000},"source":{"system":"sec-edgar","filing":"0001387131-18-005451","document":"finizio-form4_101118.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713118005451/finizio-form4_101118.xml","form_type":"4"}},{"id":3791706,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":77498,"kind":"person","name":"Finizio Robert G","position":1,"cik":"0001532235","reported_name":"Finizio Robert G","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2018-10-15T23:01:46.000Z","date":"2018-10-11","kind":"exercise","acquired":false,"shares":92000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":1012910,"derivative":{"exercise_price":0.1018,"exercise_date":"2012-01-01","expiration_date":"2019-01-01","underlying":"Common Stock","underlying_shares":92000},"source":{"system":"sec-edgar","filing":"0001387131-18-005451","document":"finizio-form4_101118.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713118005451/finizio-form4_101118.xml","form_type":"4"}},{"id":3791705,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":77498,"kind":"person","name":"Finizio Robert G","position":1,"cik":"0001532235","reported_name":"Finizio Robert G","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2018-10-15T23:01:46.000Z","date":"2018-10-12","kind":"sale","acquired":false,"shares":92000,"price":5.448,"value":501216.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales were made pursuant to the Reporting Person's 10b5-1 trading plan with respect to shares of Common Stock underlying options to purchase Common Stock that expire on or before January 1, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.37 to $5.67, inclusive. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":18393559,"source":{"system":"sec-edgar","filing":"0001387131-18-005451","document":"finizio-form4_101118.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713118005451/finizio-form4_101118.xml","form_type":"4"}},{"id":3791704,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":77498,"kind":"person","name":"Finizio Robert G","position":1,"cik":"0001532235","reported_name":"Finizio Robert G","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2018-10-15T23:01:46.000Z","date":"2018-10-12","kind":"exercise","acquired":true,"shares":92000,"price":0.1018,"value":9365.6,"ownership":{"direct":true},"balance_after":18485559,"source":{"system":"sec-edgar","filing":"0001387131-18-005451","document":"finizio-form4_101118.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713118005451/finizio-form4_101118.xml","form_type":"4"}},{"id":3791703,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":77498,"kind":"person","name":"Finizio Robert G","position":1,"cik":"0001532235","reported_name":"Finizio Robert G","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2018-10-15T23:01:46.000Z","date":"2018-10-11","kind":"sale","acquired":false,"shares":92000,"price":5.648,"value":519616.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales were made pursuant to the Reporting Person's 10b5-1 trading plan with respect to shares of Common Stock underlying options to purchase Common Stock that expire on or before January 1, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.4 to $5.75, inclusive. The reporting person undertakes to provide TherapeuticsMD, Inc. (the \"Company\"), any security holder of the Company, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":18393559,"source":{"system":"sec-edgar","filing":"0001387131-18-005451","document":"finizio-form4_101118.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713118005451/finizio-form4_101118.xml","form_type":"4"}},{"id":3791702,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":77498,"kind":"person","name":"Finizio Robert G","position":1,"cik":"0001532235","reported_name":"Finizio Robert G","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2018-10-15T23:01:46.000Z","date":"2018-10-11","kind":"exercise","acquired":true,"shares":92000,"price":0.1018,"value":9365.6,"ownership":{"direct":true},"balance_after":18485559,"source":{"system":"sec-edgar","filing":"0001387131-18-005451","document":"finizio-form4_101118.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713118005451/finizio-form4_101118.xml","form_type":"4"}},{"id":3809638,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":77498,"kind":"person","name":"Finizio Robert G","position":1,"cik":"0001532235","reported_name":"Finizio Robert G","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2018-09-24T23:01:06.000Z","date":"2018-09-21","kind":"exercise","acquired":false,"shares":92000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":1104910,"derivative":{"exercise_price":0.1018,"exercise_date":"2012-01-01","expiration_date":"2019-01-01","underlying":"Common Stock","underlying_shares":92000},"source":{"system":"sec-edgar","filing":"0001387131-18-004940","document":"finizio-form4_092018.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713118004940/finizio-form4_092018.xml","form_type":"4"}},{"id":3809637,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":77498,"kind":"person","name":"Finizio Robert G","position":1,"cik":"0001532235","reported_name":"Finizio Robert G","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2018-09-24T23:01:06.000Z","date":"2018-09-20","kind":"exercise","acquired":false,"shares":92000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":1196910,"derivative":{"exercise_price":0.1018,"exercise_date":"2012-01-01","expiration_date":"2019-01-01","underlying":"Common Stock","underlying_shares":92000},"source":{"system":"sec-edgar","filing":"0001387131-18-004940","document":"finizio-form4_092018.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713118004940/finizio-form4_092018.xml","form_type":"4"}},{"id":3809636,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":77498,"kind":"person","name":"Finizio Robert G","position":1,"cik":"0001532235","reported_name":"Finizio Robert G","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2018-09-24T23:01:06.000Z","date":"2018-09-21","kind":"sale","acquired":false,"shares":92000,"price":6.67,"value":613640.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales were made pursuant to the Reporting Person's 10b5-1 trading plan with respect to shares of Common Stock underlying options to purchase Common Stock that expire on or before January 1, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.51 to $6.92, inclusive. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":18393559,"source":{"system":"sec-edgar","filing":"0001387131-18-004940","document":"finizio-form4_092018.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713118004940/finizio-form4_092018.xml","form_type":"4"}},{"id":3809635,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":77498,"kind":"person","name":"Finizio Robert G","position":1,"cik":"0001532235","reported_name":"Finizio Robert G","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2018-09-24T23:01:06.000Z","date":"2018-09-21","kind":"exercise","acquired":true,"shares":92000,"price":0.1018,"value":9365.6,"ownership":{"direct":true},"balance_after":18485559,"source":{"system":"sec-edgar","filing":"0001387131-18-004940","document":"finizio-form4_092018.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713118004940/finizio-form4_092018.xml","form_type":"4"}},{"id":3809634,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":77498,"kind":"person","name":"Finizio Robert G","position":1,"cik":"0001532235","reported_name":"Finizio Robert G","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2018-09-24T23:01:06.000Z","date":"2018-09-20","kind":"sale","acquired":false,"shares":92000,"price":6.58,"value":605360.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales were made pursuant to the Reporting Person's 10b5-1 trading plan with respect to shares of Common Stock underlying options to purchase Common Stock that expire on or before January 1, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.32 to $6.755, inclusive. The reporting person undertakes to provide TherapeuticsMD, Inc. (the \"Company\"), any security holder of the Company, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":18393559,"source":{"system":"sec-edgar","filing":"0001387131-18-004940","document":"finizio-form4_092018.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713118004940/finizio-form4_092018.xml","form_type":"4"}},{"id":3809633,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":77498,"kind":"person","name":"Finizio Robert G","position":1,"cik":"0001532235","reported_name":"Finizio Robert G","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2018-09-24T23:01:06.000Z","date":"2018-09-20","kind":"exercise","acquired":true,"shares":92000,"price":0.1018,"value":9365.6,"ownership":{"direct":true},"balance_after":18485559,"source":{"system":"sec-edgar","filing":"0001387131-18-004940","document":"finizio-form4_092018.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713118004940/finizio-form4_092018.xml","form_type":"4"}},{"id":3821640,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":77498,"kind":"person","name":"Finizio Robert G","position":1,"cik":"0001532235","reported_name":"Finizio Robert G","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2018-09-10T23:00:55.000Z","date":"2018-09-07","kind":"exercise","acquired":false,"shares":92000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":1288910,"derivative":{"exercise_price":0.1018,"exercise_date":"2012-01-01","expiration_date":"2019-01-01","underlying":"Common Stock","underlying_shares":92000},"source":{"system":"sec-edgar","filing":"0001387131-18-004627","document":"finizio-form4_090618.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713118004627/finizio-form4_090618.xml","form_type":"4"}},{"id":3821639,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":77498,"kind":"person","name":"Finizio Robert G","position":1,"cik":"0001532235","reported_name":"Finizio Robert G","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2018-09-10T23:00:55.000Z","date":"2018-09-06","kind":"exercise","acquired":false,"shares":92000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":1380910,"derivative":{"exercise_price":0.1018,"exercise_date":"2012-01-01","expiration_date":"2019-01-01","underlying":"Common Stock","underlying_shares":92000},"source":{"system":"sec-edgar","filing":"0001387131-18-004627","document":"finizio-form4_090618.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713118004627/finizio-form4_090618.xml","form_type":"4"}},{"id":3821638,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":77498,"kind":"person","name":"Finizio Robert G","position":1,"cik":"0001532235","reported_name":"Finizio Robert G","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2018-09-10T23:00:55.000Z","date":"2018-09-07","kind":"sale","acquired":false,"shares":92000,"price":6.22,"value":572240.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales were made pursuant to the Reporting Person's 10b5-1 trading plan with respect to shares of Common Stock underlying options to purchase Common Stock that expire on or before January 1, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.095 to $6.31, inclusive. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":18393559,"source":{"system":"sec-edgar","filing":"0001387131-18-004627","document":"finizio-form4_090618.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713118004627/finizio-form4_090618.xml","form_type":"4"}},{"id":3821637,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":77498,"kind":"person","name":"Finizio Robert G","position":1,"cik":"0001532235","reported_name":"Finizio Robert G","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2018-09-10T23:00:55.000Z","date":"2018-09-07","kind":"exercise","acquired":true,"shares":92000,"price":0.1018,"value":9365.6,"ownership":{"direct":true},"balance_after":18485559,"source":{"system":"sec-edgar","filing":"0001387131-18-004627","document":"finizio-form4_090618.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713118004627/finizio-form4_090618.xml","form_type":"4"}},{"id":3821636,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":77498,"kind":"person","name":"Finizio Robert G","position":1,"cik":"0001532235","reported_name":"Finizio Robert G","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2018-09-10T23:00:55.000Z","date":"2018-09-06","kind":"sale","acquired":false,"shares":92000,"price":6.25,"value":575000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales were made pursuant to the Reporting Person's 10b5-1 trading plan with respect to shares of Common Stock underlying options to purchase Common Stock that expire on or before January 1, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.145 to $6.385, inclusive. The reporting person undertakes to provide TherapeuticsMD, Inc. (the \"Company\"), any security holder of the Company, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":18393559,"source":{"system":"sec-edgar","filing":"0001387131-18-004627","document":"finizio-form4_090618.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713118004627/finizio-form4_090618.xml","form_type":"4"}},{"id":3821635,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":77498,"kind":"person","name":"Finizio Robert G","position":1,"cik":"0001532235","reported_name":"Finizio Robert G","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2018-09-10T23:00:55.000Z","date":"2018-09-06","kind":"exercise","acquired":true,"shares":92000,"price":0.1018,"value":9365.6,"ownership":{"direct":true},"balance_after":18485559,"source":{"system":"sec-edgar","filing":"0001387131-18-004627","document":"finizio-form4_090618.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713118004627/finizio-form4_090618.xml","form_type":"4"}},{"id":3991464,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":77498,"kind":"person","name":"Finizio Robert G","position":1,"cik":"0001532235","reported_name":"Finizio Robert G","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2018-03-19T21:50:26.000Z","date":"2018-03-15","kind":"grant","acquired":true,"shares":440000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Underlying shares vest as follows: 146,667 shares on the first anniversary date of the grant, 146,667 shares on the second anniversary date of the grant, and 146,666 shares on the third anniversary date of the grant."}],"balance_after":440000,"derivative":{"exercise_price":5.16,"exercise_date":"2019-03-15","expiration_date":"2028-03-15","underlying":"Common Stock","underlying_shares":440000},"source":{"system":"sec-edgar","filing":"0001387131-18-001129","document":"finizio-form4_031518.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713118001129/finizio-form4_031518.xml","form_type":"4"}},{"id":4067891,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":77498,"kind":"person","name":"Finizio Robert G","position":1,"cik":"0001532235","reported_name":"Finizio Robert G","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2018-02-13T02:17:12.000Z","date":"2017-12-01","kind":"gift","acquired":false,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":18393559,"source":{"system":"sec-edgar","filing":"0001387131-18-000565","document":"finizio-form5_123117.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713118000565/finizio-form5_123117.xml","form_type":"5"}},{"id":4381754,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":77498,"kind":"person","name":"Finizio Robert G","position":1,"cik":"0001532235","reported_name":"Finizio Robert G","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO"}}],"security":"Non-qualified stock option (right to buy)","published_at":"2017-03-17T22:31:04.000Z","date":"2017-03-15","kind":"grant","acquired":true,"shares":445000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Underlying shares vest as follows: 148,333 shares on the first anniversary date of the grant, 148,333 shares on the second anniversary date of the grant, and 148,334 shares on the third anniversary date of the grant."}],"balance_after":445000,"derivative":{"exercise_price":6.83,"exercise_date":"2018-03-15","expiration_date":"2027-03-14","underlying":"Common Stock","underlying_shares":445000},"source":{"system":"sec-edgar","filing":"0001387131-17-001456","document":"finizio-form4_031517.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713117001456/finizio-form4_031517.xml","form_type":"4"}},{"id":4453009,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":77498,"kind":"person","name":"Finizio Robert G","position":1,"cik":"0001532235","reported_name":"Finizio Robert G","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2017-02-14T22:55:36.000Z","date":"2016-12-30","kind":"gift","acquired":false,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":18643559,"source":{"system":"sec-edgar","filing":"0001387131-17-000843","document":"robert_finizio-form5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713117000843/robert_finizio-form5.xml","form_type":"5"}},{"id":4453008,"issuer":{"id":7541,"kind":"organization","name":"TherapeuticsMD, Inc."},"owners":[{"id":77498,"kind":"person","name":"Finizio Robert G","position":1,"cik":"0001532235","reported_name":"Finizio Robert G","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2017-02-14T22:55:36.000Z","date":"2016-12-29","kind":"gift","acquired":false,"shares":165000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 20,000 shares of Common Stock that were inadvertently reported as being disposed of by gift on the Reporting Person's Form 5 filed with the SEC on February 16, 2016."}],"balance_after":18651059,"source":{"system":"sec-edgar","filing":"0001387131-17-000843","document":"robert_finizio-form5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/25743/000138713117000843/robert_finizio-form5.xml","form_type":"5"}}]}